End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.99 CNY | +0.49% | -1.07% | +7.04% |
May. 07 | Mabwell Announces FDA Grants Orphan Drug Designation to 9MW2821 | CI |
Apr. 29 | Mabwell Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Mabwell (Shanghai) Bioscience Co., Ltd.
Upcoming events on Mabwell (Shanghai) Bioscience Co., Ltd.
Past events on Mabwell (Shanghai) Bioscience Co., Ltd.
2024-04-29 | Q1 2024 Earnings Release |
2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Abstract Number: 6349 |
2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Abstract Number: 6350 |
2024-04-08 | Q4 2023 Earnings Release |
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract Number: 2365 |
2024-03-16 06:00 pm | Society of Gynecologic Oncology Meeting |
2024-03-13 | World Antibody-Drug Conjugate Conference |
2024-01-09 12:30 pm | JPMorgan Healthcare Conference |
2023-10-25 | Q3 2023 Earnings Release |
2023-10-19 | European Society for Medical Oncology Congress - Abstract Number: 3602 |
2023-10-19 | European Society for Medical Oncology Congress - Abstract Number: 4613 |
2023-08-06 | Q2 2023 Earnings Release |
2023-04-24 | Q1 2023 Earnings Release |
2023-04-06 | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 0,00 | 128 247 -48.37% | 385 |
EBITDA Million CNY | Released Forecast Spread | 0,00 | -973 -818 -19.02% | -751 |
EBIT Million CNY | Released Forecast Spread | 0,00 | -1 053 -947 -11.16% | -908 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | -1 056 -914 -15.51% | -864 |
Net income Million CNY | Released Forecast Spread | -954 | -1 053 -912 -15.53% | -862 |
EPS CNY | Released Forecast Spread | -2,44 | -2,64 -2,28 -15.62% | -2,16 |
Announcement Date | 20/02/23 | 23/02/24 | - |
Past sector events for Mabwell (Shanghai) Bioscience Co., Ltd.
2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:15 pm | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
2024-05-09 04:10 pm | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:09 pm | XENCOR, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688062 Stock
- Calendar Mabwell (Shanghai) Bioscience Co., Ltd.